Free Trial

Integer (ITGR) Competitors

Integer logo
$133.67 +0.78 (+0.59%)
(As of 12/20/2024 05:16 PM ET)

ITGR vs. PODD, HOLX, BAX, GMED, MASI, TFX, IART, ATRC, ATEC, and OFIX

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), Integra LifeSciences (IART), AtriCure (ATRC), Alphatec (ATEC), and Orthofix Medical (OFIX). These companies are all part of the "health care equipment" industry.

Integer vs.

Integer (NYSE:ITGR) and Insulet (NASDAQ:PODD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, community ranking, institutional ownership and profitability.

Integer presently has a consensus price target of $145.44, indicating a potential upside of 8.81%. Insulet has a consensus price target of $269.40, indicating a potential upside of 1.06%. Given Integer's stronger consensus rating and higher probable upside, research analysts clearly believe Integer is more favorable than Insulet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Insulet
0 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.80

99.3% of Integer shares are held by institutional investors. 2.0% of Integer shares are held by company insiders. Comparatively, 0.5% of Insulet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Integer has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Insulet has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500.

Insulet has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.71B2.62$90.65M$3.2441.26
Insulet$1.98B9.43$206.30M$5.8445.65

Insulet received 339 more outperform votes than Integer when rated by MarketBeat users. Likewise, 66.27% of users gave Insulet an outperform vote while only 63.92% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
388
63.92%
Underperform Votes
219
36.08%
InsuletOutperform Votes
727
66.27%
Underperform Votes
370
33.73%

Insulet has a net margin of 21.22% compared to Integer's net margin of 6.70%. Insulet's return on equity of 27.98% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.70% 11.63% 5.86%
Insulet 21.22%27.98%9.16%

In the previous week, Insulet had 2 more articles in the media than Integer. MarketBeat recorded 5 mentions for Insulet and 3 mentions for Integer. Integer's average media sentiment score of 1.70 beat Insulet's score of 1.21 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Insulet
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Insulet beats Integer on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$4.48B$3.01B$5.10B$19.18B
Dividend YieldN/A1.75%4.90%3.58%
P/E Ratio41.2616.1590.8741.22
Price / Sales2.6250.121,112.6717.58
Price / Cash17.7039.9142.1421.28
Price / Book2.933.724.785.32
Net Income$90.65M$89.83M$119.77M$989.67M
7 Day Performance-3.63%-1.82%-1.87%-3.45%
1 Month Performance-1.74%0.28%11.46%-3.73%
1 Year Performance35.24%4.10%30.49%12.06%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
2.8706 of 5 stars
$133.67
+0.6%
$145.44
+8.8%
+36.4%$4.48B$1.71B41.2610,500Positive News
PODD
Insulet
4.2543 of 5 stars
$265.75
-1.3%
$267.44
+0.6%
+28.2%$18.64B$1.70B46.123,000Positive News
HOLX
Hologic
4.7212 of 5 stars
$73.06
-0.8%
$89.50
+22.5%
+1.9%$16.58B$4.03B22.147,063Analyst Forecast
BAX
Baxter International
4.5379 of 5 stars
$29.52
-2.6%
$40.45
+37.0%
-23.6%$15.07B$15.06B149.2060,000Options Volume
GMED
Globus Medical
4.8821 of 5 stars
$82.27
-0.2%
$92.18
+12.0%
+59.4%$11.20B$2.48B122.675,000Analyst Forecast
Analyst Revision
MASI
Masimo
3.5617 of 5 stars
$176.61
+0.3%
$170.67
-3.4%
+49.0%$9.46B$2.04B121.485,200Analyst Forecast
TFX
Teleflex
4.8955 of 5 stars
$178.90
-0.7%
$259.00
+44.8%
-28.0%$8.31B$2.97B35.8114,500Analyst Forecast
IART
Integra LifeSciences
3.9715 of 5 stars
$24.05
+0.1%
$23.00
-4.4%
-49.5%$1.86B$1.56B-267.003,946Positive News
ATRC
AtriCure
3.3567 of 5 stars
$31.64
-0.1%
$42.00
+32.7%
-10.9%$1.54B$447.57M-38.161,200Analyst Forecast
Positive News
ATEC
Alphatec
3.8918 of 5 stars
$9.48
-1.5%
$17.11
+80.5%
-35.5%$1.34B$572.74M-7.52700
OFIX
Orthofix Medical
2.9588 of 5 stars
$18.22
+1.4%
$23.00
+26.2%
+30.1%$696.19M$746.64M0.001,634Positive News

Related Companies and Tools


This page (NYSE:ITGR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners